Chronic Myelomonocytic Leukemia Not Yet Recruiting Phase 2 Trials for Cefotaxime (DB00493)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03602898Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationTreatment